专利检索 ap:("INSTITUT GUSTAVE ROUSSY" OR "ISTITUTO EUROPEO DI ONCOLOGIA (IEO)") AND inv:"Carmen Criscitiello" 第 1 页

1.

发明授权
Use of the expression of specific genes for the prognosis of patients with triple negative breast cancer 有权

公开(公告)号：US11466327B2

公开(公告)日：2022-10-11

申请号：US16313659

申请日：2017-07-03

申请人： INSTITUT GUSTAVE ROUSSY , ISTITUTO EUROPEO DI ONCOLOGIA (IEO)

发明人： Michiels Stefan , Mohamed Amine Bayar , Fabrice Andre , Carmen Criscitiello , Giuseppe Curigliano

IPC分类号： C12Q1/6886

摘要： The present invention relates to the use of the value of the expression of at least one gene selected from the group comprising: GBP 1 gene, HLF gene, CXCL13 gene and SULT1E1 gene, for the estimation of prognosis of distant relapse-free survival or overall survival of a patient with triple negative breast cancer (TNBC) having received a neoadjuvant chemotherapy (NACT).